PFE : NYSE : Health Care
$33.215 -0.14 | -0.43%
Today's Range: 33.18 - 33.45
Avg. Daily Volume: 1.87128E7
08/17/17 - 12:08 PM ET

Financial Analysis


PFIZER INC's gross profit margin for the second quarter of its fiscal year 2017 has decreased when compared to the same period a year ago. Even though sales decreased, the net income has increased, representing an increase to the bottom line.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.



Income Statement Q2 FY17 Q2 FY16
Net Sales ($mil)12896.013147.0
EBITDA ($mil)0.05267.0
EBIT ($mil)3916.03880.0
Net Income ($mil)3073.02020.0


Balance Sheet Q2 FY17 Q2 FY16
Cash & Equiv. ($mil)0.020943.0
Total Assets ($mil)0.0170658.0
Total Debt ($mil)0.044182.0
Equity ($mil)0.062769.0


Profitability Q2 FY17 Q2 FY16
Gross Profit Margin70.4179.55
EBITDA Margin0.040.06
Operating Margin30.3729.51
Sales Turnover0.00.31
Return on Assets0.04.11
Return on Equity0.011.16
Debt Q2 FY17 Q2 FY16
Current Ratio0.01.37
Debt/Capital0.00.41
Interest Expense0.0308.0
Interest Coverage0.012.6


Share Data Q2 FY17 Q2 FY16
Shares outstanding (mil)5967.846065.65
Div / share0.320.3
EPS0.510.33
Book value / share0.010.35
Institutional Own % n/a n/a
Avg Daily Volume1.9572408E72.2808548E7

Valuation


BUY. PFIZER INC's P/E ratio indicates a discount compared to an average of 28.08 for the Pharmaceuticals industry and a value on par with the S&P 500 average of 24.31. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average. After reviewing these and other key valuation criteria, PFIZER INC proves to trade at a discount to investment alternatives within the industry.


Price/Earnings
1 2 3 4 5
premium   discount
  Price/Cash Flow
1 2 3 4 5
premium   discount
PFE 24.39 Peers 28.08   PFE NA Peers 25.61

Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.

PFE is trading at a discount to its peers.

 

Neutral. The P/CF ratio is the stock’s price divided by the sum of the company's cash flow from operations. It is useful for comparing companies with different capital requirements or financing structures.

Ratio not available.

 
Price/Projected
Earnings
1 2 3 4 5
premium   discount
  Price to
Earnings/Growth
1 2 3 4 5
premium   discount
PFE 12.15 Peers 14.98   PFE 0.21 Peers 0.61

Discount. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth expectations.

PFE is trading at a discount to its peers.

 

Discount. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.

PFE trades at a significant discount to its peers.

 
Price/Book
1 2 3 4 5
premium   discount
  Earnings Growth
1 2 3 4 5
lower   higher
PFE NA Peers 16.44   PFE 21.23 Peers 25.27

Neutral. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.

Ratio not available.

 

Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.

However, PFE is expected to trail its peers on the basis of its earnings growth rate.

 
Price/Sales
1 2 3 4 5
premium   discount
  Sales Growth
1 2 3 4 5
premium   discount
PFE 3.81 Peers 6.45   PFE 0.11 Peers 8.29

Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.

PFE is trading at a significant discount to its industry on this measurement.

 

Lower. A sales growth rate that trails the industry implies that a company is losing market share.

PFE significantly trails its peers on the basis of sales growth

 

 

Latest Stock Upgrades/Downgrades